These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 17845895

  • 1. Plasma protein lipofuscin-like fluorophores in men with coronary artery disease treated with statins.
    Sutherland WH, Williams MJ, de Jong SA.
    Arch Med Res; 2007 Oct; 38(7):757-63. PubMed ID: 17845895
    [Abstract] [Full Text] [Related]

  • 2. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):973-9. PubMed ID: 16949489
    [Abstract] [Full Text] [Related]

  • 3. Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.
    Ndrepepa G, Braun S, von Beckerath N, Mehilli J, Gorchakova O, Vogt W, Schömig A, Kastrati A.
    Clin Chim Acta; 2005 Oct 05; 360(1-2):178-86. PubMed ID: 15993392
    [Abstract] [Full Text] [Related]

  • 4. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
    Granér M, Kahri J, Nakano T, Sarna SJ, Nieminen MS, Syvänne M, Taskinen MR.
    Eur J Clin Invest; 2006 Nov 05; 36(11):764-70. PubMed ID: 17032343
    [Abstract] [Full Text] [Related]

  • 5. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S.
    Blood Purif; 2007 Nov 05; 25(5-6):457-65. PubMed ID: 18075247
    [Abstract] [Full Text] [Related]

  • 6. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S, MIRACL Study Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2186-96. PubMed ID: 19497447
    [Abstract] [Full Text] [Related]

  • 7. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
    Ky B, Burke A, Tsimikas S, Wolfe ML, Tadesse MG, Szapary PO, Witztum JL, FitzGerald GA, Rader DJ.
    J Am Coll Cardiol; 2008 Apr 29; 51(17):1653-62. PubMed ID: 18436117
    [Abstract] [Full Text] [Related]

  • 8. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D, Sönmez H, Ekmekçi H, Ulutin T, Oztürk Z, Kökoğlu E, Bayram C, Soner A, Domaniç N.
    Clin Biochem; 2005 Jan 29; 38(1):92-6. PubMed ID: 15607324
    [Abstract] [Full Text] [Related]

  • 9. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
    Piechota W, Piechota W.
    Pol Merkur Lekarski; 2005 May 29; 18(107):511-5. PubMed ID: 16161944
    [Abstract] [Full Text] [Related]

  • 10. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO, Borlaug BA, Johnston PV, Kral BG, Rouf R, Blumenthal RS, Kwiterovich PO.
    J Am Coll Cardiol; 2007 Oct 30; 50(18):1735-41. PubMed ID: 17964036
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Apolipoproteins as markers and managers of coronary risk.
    Chan DC, Watts GF.
    QJM; 2006 May 30; 99(5):277-87. PubMed ID: 16504986
    [Abstract] [Full Text] [Related]

  • 14. Hypochlorous acid and 3,4-dihydroxyphenylalanine increase the formation of serum protein lipofuscin-like fluorophores in vitro.
    Sutherland WH, de Jong SA, Walker RJ.
    Ren Fail; 2005 May 30; 27(2):239-46. PubMed ID: 15807192
    [Abstract] [Full Text] [Related]

  • 15. South-to-North gradient in lipid peroxidation in men with stable coronary artery disease in Europe.
    Grau M, Guxens M, Subirana I, Fitó M, Covas MI, Jacquemin B, Sunyer J, Lanki T, Picciotto S, Bellander T, Katsouyanni K, Schneider A, Peters A, Marrugat J, AIRGENE Study Group.
    Eur Heart J; 2007 Dec 30; 28(23):2841-9. PubMed ID: 17947215
    [Abstract] [Full Text] [Related]

  • 16. Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men.
    Chan DC, Watts GF, Wang J, Hegele RA, van Bockxmeer FM, Barrett PH.
    Clin Endocrinol (Oxf); 2008 Jul 30; 69(1):45-51. PubMed ID: 18031309
    [Abstract] [Full Text] [Related]

  • 17. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease.
    Kamezaki F, Yamashita K, Tasaki H, Kume N, Mitsuoka H, Kita T, Adachi T, Otsuji Y.
    Int J Cardiol; 2009 May 15; 134(2):285-7. PubMed ID: 18367271
    [Abstract] [Full Text] [Related]

  • 18. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK, Juenger C, Jannowitz C, Karmann B, Senges J, Bestehorn K.
    Eur J Cardiovasc Prev Rehabil; 2009 Aug 15; 16(4):438-44. PubMed ID: 19369876
    [Abstract] [Full Text] [Related]

  • 19. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Witztum JL, Strauss BH.
    Circulation; 2004 Jun 29; 109(25):3164-70. PubMed ID: 15184281
    [Abstract] [Full Text] [Related]

  • 20. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
    Serdar Z, Yeşilbursa D, Dirican M, Sarandöl E, Serdar A.
    Cell Biochem Funct; 2007 Jun 29; 25(6):655-64. PubMed ID: 17006879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.